The IMA Group Acquires New York's Medical Research Network
TARRYTOWN, N.Y., July 21, 2025--(BUSINESS WIRE)--The IMA Group (IMA) today announced the acquisition of Medical Research Network (MRN) LLC, a U.S.-based clinical research site located in New York City, specializing in psychiatry and neurology trials focused on central nervous system (CNS) disorders.
Terms of the transaction were not disclosed. Founded in 1997, MRN will continue operating under its current name and leadership, with core investigators and staff remaining in place, led by Founder, CEO, and Principal Investigator Michael R. Liebowitz, MD.
Dr. Liebowitz is Board Certified in Psychiatry and has devoted more than 30 years to the research and treatment of anxiety, phobic, and affective disorders. He previously chaired the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) Workgroup on Anxiety Disorders. His contributions to the psychiatric and research fields span social anxiety, obsessive-compulsive disorder, panic disorder, atypical depression, and rapid cycling mood disorders.
"The need for high-quality clinical research in mental health continues to grow, particularly as we confront rising demand for care and long-standing gaps in access," said Dr. Liebowitz. "By combining our deep CNS expertise and well-established clinical operations with IMA's growing national platform, we're positioned to reach more diverse and underserved patient populations, accelerate access to promising treatments, and deliver outstanding value to sponsors."
Mark Weinberger, PhD, MPH, President and CEO of The IMA Group, emphasized how the acquisition enhances IMA's operational capacity to meet sponsor needs. "By integrating MRN's experienced team and established site into our network, we're strengthening our ability to deliver efficient, high-performing trials in the CNS space," he said. "This addition helps us reduce time to first patient, ensure quality data capture, and provide the scale and consistency that today's sponsors require to execute successful studies."
The acquisition adds IMA's second research site in New York City and its first East Coast location dedicated to CNS trials. It builds on IMA's existing CNS-focused presence in Phoenix, Las Vegas, and Albuquerque—expanding the company's national footprint in this key therapeutic area. The move also aligns with the company's broader strategy to grow both organically and through acquisitions—positioning IMA as one of the nation's leading independent providers of outsourced healthcare evaluation and clinical research services.
About The IMA Group:For over 30 years, The IMA Group, headquartered in New York, has been focused on enhancing the livelihood and productivity of individuals and organizations through a comprehensive range of Medical and Behavioral Health Services and Clinical Research at more than 150 sites and our large, affiliated provider network. The IMA Group serves the nation's top government and payer organizations through a range of Occupational Health, Workers' Compensation, Auto Insurance, and Employer Solutions. The company's Evaluation Services spans disability and independent medical exams (IME), case management services, fitness for duty/pre-employment evaluations, medical/psychological/ancillary exams, and a variety of occupational health services. IMA Clinical Research offers site-based, hybrid, and fully decentralized clinical trials that support the development of novel medicines, vaccines, and devices. Additionally, The IMA Group is unique in the marketplace in that it can bring together expertise in Evaluation Services and Clinical Research. For more information, visit www.theimagroup.com or www.imaresearch.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250721283180/en/
Contacts
For more information, contact: Brenna Harrington706-217-7809brenna@harringtonpr.biz
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
First-ever RWA tokenization ETF by Ondo Finance filed by 21Shares
First-ever RWA tokenization ETF by Ondo Finance filed by 21Shares originally appeared on TheStreet. 21Shares has submitted a Form S-1 with the U.S. Securities and Exchange Commission (SEC) on July 23 for an ETF tracking ONDO, the native token of Ondo Finance. If passed, it would also be the first US-based ETF targeted at a token that supports a real-world asset (RWA) tokenization platform. The filing—made under "21Shares Ondo Trust"—suggests a growing appetite among institutional investors for tokenized finance, with a focus on blockchain-based replicas of traditional financial products, in this case U.S. Treasuries. Earlier, on June 11, Ondo Finance launched tokenized US securities on the XRPL ledger via Ripple's Finance is one of the leading players in this space, offering tokenized Treasury products such as OUSG to enable crypto-native users to access stable, yield-bearing assets. The Ondo module is the governance token and incentive layer for the platform, providing access to future financial products within the ecosystem. According to the firm behind 21Shares, over $1.5 billion of U.S. Treasuries have been tokenized, and the firm is a significant part of that aggregate. The filing also comes at a time of a marked increase in interest in ETFs. Ethereum ETFs reported $533.8 million in inflows on a single day while cumulative net inflow stands at $8.32 billion, as per SoSoValue. Further, Bitcoin ETFs saw a cumulative inflow of $54.55 billion. The two trends—more people wanting to invest in crypto ETs, along with institutions wanting tokenized RWAs—could be the start of a shift in crypto ETFs investing in more than just BTC and ETH. First-ever RWA tokenization ETF by Ondo Finance filed by 21Shares first appeared on TheStreet on Jul 23, 2025 This story was originally reported by TheStreet on Jul 23, 2025, where it first appeared.
Fast Company
3 hours ago
- Fast Company
Stocks rise to more records after U.S. strikes trade deal with Japan
BY U.S. stocks are rising toward more records on Wednesday following a trade deal between the world's No. 1 and No. 4 economies, one that would lower proposed tariffs on Japanese imports coming to the United States. The S&P 500 was 0.7% higher, coming off its latest all-time high. The Dow Jones Industrial Average was up 469 points, or 1.1%, with a little less than an hour remaining in trading, and the Nasdaq composite was 0.5% higher and heading for its own record. Stocks jumped even more in Tokyo, where the Nikkei 225 rallied 3.5% after President Donald Trump announced a trade framework that would place a 15% tax on imports coming from Japan. That's lower than the 25% rate that Trump had earlier said would kick in on Aug. 1. 'It's a sign of the times that markets would cheer 15% tariffs,' said Brian Jacobsen, chief economist at Annex Wealth Management. 'A year ago, that level of tariffs would be shocking. Today, we breathe a sigh of relief.' Trump has proposed stiff taxes on imports from around the world, which carry the double-edged risk of driving up inflation for U.S. households while slowing the economy. But many of Trump's tariffs are currently on pause, giving time to reach deals with other countries that could lower the tax rates. Trump also announced a trade agreement with the Philippines on Tuesday. So far, the U.S. economy has seemed to hold up OK despite the pressures on it. And tariffs already in place may be having less of an effect than expected, at least when it comes to the prices that U.S. households are paying at the moment. 'The main lesson about tariffs so far is that passthrough to consumer prices is tracking somewhat lower than in 2019,' according to Goldman Sachs economist David Mericle. Tariffs are certainly having an effect, to be sure, as big U.S. companies across industries have been demonstrating through their profit updates in recent days. Hasbro took a $1 billion, non-cash hit to its results for the spring to write down the value of some of its assets following a review triggered by the implementation of tariffs. It said tariffs have had no impact yet on how much profit it's making from each $1 of its sales, but it expects to see costs ramp during the current quarter. Hasbro's stock fell 0.8% even though it reported a stronger profit for the latest quarter than analysts expected, when not including the $1 billion charge. Like the toymaker, Texas Instruments' stock also fell despite delivering results for the latest quarter that were above analysts' expectations. It gave a forecasted range for profit in the current quarter whose midpoint fell a bit shy of Wall Street's. Analysts pointed to some cautious commentary from Texas Instruments executives about how the uncertainty created by tariffs could slow demand. Its stock sank 13.4%. Most of the stocks on Wall Street nevertheless rose, including a 14.2% jump for GE Vernova's stock. The energy company not only delivered a stronger profit than analysts expected, it also raised its forecasts for revenue from its power and electrification businesses. GE Vernova said that the inflation it's expecting to see as a result of tariffs may be trending toward the lower end of $300 million to $400 million, net of mitigating actions. Lamb Weston rallied 15.3% after the supplier of French fries and other potato products delivered better results for the latest quarter than analysts expected and said it expects customers will continue to eat fries even with an uncertain economy. It also announced a plan to cut at least $250 million in costs by cutting about 4% of its workforce and making other moves. Elsewhere on Wall Street, several stocks jumped as traders search for the next 'meme stock' that could ride a wave of online enthusiasm to high prices, regardless of what the company's profits are doing. Krispy Kreme, which came into the day with a 58.4% loss for the year so far, jumped nearly 39% shortly after trading began. It gave back most of those gains as the day continued and was up 4.6% in afternoon trading. GoPro gained 12.4%. That's even as other potential meme stocks lost their momentum. Opendoor Technologies, which had more than tripled between the last two Mondays, fell 17%. In stock markets abroad, indexes rose across Asia and Europe following Trump's announcements of trade deals. Japan's market was the big winner, where a series of automakers gave no public reaction as their stock prices rallied. Japanese companies tend to be cautious about their public reactions, and some business officials have privately remarked in off-record comments that they hesitate to say anything because Trump keeps changing his mind. Elsewhere, Hong Kong's Hang Seng rose 1.6%, and France's CAC 40 gained 1.4% for two of the world's bigger moves. In the bond market, Treasury yields ticked higher. The yield on the 10-year Treasury rose to 4.38% from 4.35% late Tuesday. —Stan Choe, AP business writer AP Business Writer Yuri Kageyama contributed. The super-early-rate deadline for Fast Company's Most Innovative Companies Awards is this Friday, July 25, at 11:59 p.m. PT. Apply today.
Yahoo
5 hours ago
- Yahoo
Takeaways of US-Japan deal include potential gains for Trump, Ishiba and EU
(Reuters) -An emerging U.S.-Japanese trade deal could unlock major investment, avert a potential shock to the global economy and may deliver political wins for both U.S. President Donald Trump and Japanese Prime Minister Shigeru Ishiba, though many specifics of the agreement remain unclear. Here's a closer look at the early takeaways: * The deal stabilizes the global trade outlook by imposing a 15% tariff on Japanese goods — down from a threatened 25% — while Japan commits to investing $550 billion in the U.S. economy, a boost to U.S. jobs. It almost certainly averts a worst-case scenario for the Japanese economy. Moreover, if it signals that the balance of U.S. tariff rates are likely to settle in that range, Jefferies Chief Economist and Strategist for Europe Mohit Kumar said: "the world can live with 15% or so tariffs." * Trump gains some political capital ahead of November 2026 midterm elections by reinforcing his 'America First' trade stance and potentially bolstering his influence with industrial and agricultural constituencies while avoiding the market instability that loomed under earlier tariff threats. Still, not every U.S. constituency was happy with the announcement. The decision has angered the Detroit Three automakers, who still face a 25% levy on significant segments of their non-U.S. produced vehicles. * For Ishiba, the deal is a diplomatic and economic win amid domestic political turbulence. Just days earlier, Japan's ruling coalition lost its majority in upper house elections. * Analysts say the deal could serve as a benchmark for other economies negotiating with Washington, including the EU and China, both facing August tariff deadlines. * American exporters could gain broader access to Japan's markets, especially in autos and agriculture — sectors vital to U.S. economic growth. * Global financial markets are rallying led by automakers. Stocks of major Japanese firms surged following the announcement, and capital inflows are expected to continue as investors seek exposure to Japan's innovation-led growth. * Despite the investment commitments, the deal may not significantly reduce the U.S. trade deficit with Japan in the short term. Critics argue that without stronger enforcement mechanisms or structural reforms, the imbalance could persist. * A 15% tariff, though lower than the threatened 25%, still represents a significantly higher import tax for consumer goods, especially for cars and electronics, which are heavily imported to the U.S. from Japan. Yale Budget Lab last week estimated the overall average U.S. tariff rate under Trump's policy shifts has climbed to around 20% from between 2% and 3% prior to his return to the White House in January.
